S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
S&P 500   3,372.85 (-0.02%)
DOW   27,931.02 (+0.12%)
QQQ   272.16 (-0.12%)
AAPL   459.63 (-0.09%)
MSFT   208.90 (+0.10%)
FB   261.24 (-0.02%)
GOOGL   1,504.63 (-0.79%)
AMZN   3,148.02 (-0.41%)
NVDA   462.56 (+1.06%)
CGC   17.19 (-0.75%)
BABA   253.97 (+0.10%)
TSLA   1,650.71 (+1.83%)
GE   6.66 (+0.91%)
MU   45.60 (-1.17%)
AMD   81.30 (-0.66%)
T   30.01 (+0.33%)
F   7.04 (+0.14%)
ACB   10.69 (+5.01%)
GILD   68.50 (+0.47%)
NFLX   482.68 (+0.28%)
DIS   130.53 (-0.33%)
BAC   26.47 (+0.46%)
BA   178.08 (+1.92%)
Log in

NASDAQ:HQYHealthequity Stock Price, Forecast & News

$57.97
-0.46 (-0.79 %)
(As of 08/14/2020 04:00 PM ET)
Add
Compare
Today's Range
$56.70
Now: $57.97
$58.30
50-Day Range
$51.12
MA: $56.24
$62.05
52-Week Range
$34.40
Now: $57.97
$88.78
Volume482,799 shs
Average Volume956,116 shs
Market Capitalization$4.14 billion
P/E Ratio1,932.33
Dividend YieldN/A
Beta1.43
HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers health reimbursement and flexible spending arrangements solutions; and Employee Retirement Income Security Act's plan administration and investment services. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah.
Read More
Healthequity logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.37 out of 5 stars


Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HQY
CUSIPN/A
Phone801-727-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$531.99 million
Cash Flow$2.39 per share
Book Value$14.54 per share

Profitability

Net Income$39.66 million

Miscellaneous

Employees2,931
Market Cap$4.14 billion
Next Earnings Date9/8/2020 (Confirmed)
OptionableOptionable
$57.97
-0.46 (-0.79 %)
(As of 08/14/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HQY News and Ratings via Email

Sign-up to receive the latest news and ratings for HQY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Healthequity (NASDAQ:HQY) Frequently Asked Questions

How has Healthequity's stock price been impacted by Coronavirus?

Healthequity's stock was trading at $50.32 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, HQY stock has increased by 15.2% and is now trading at $57.97.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Healthequity?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 3 hold ratings, 9 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Healthequity
.

When is Healthequity's next earnings date?

Healthequity is scheduled to release its next quarterly earnings announcement on Tuesday, September 8th 2020.
View our earnings forecast for Healthequity
.

How can I listen to Healthequity's earnings call?

Healthequity will be holding an earnings conference call on Tuesday, September 8th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Healthequity's earnings last quarter?

Healthequity Inc (NASDAQ:HQY) released its quarterly earnings results on Tuesday, June, 2nd. The company reported $0.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.44 by $0.01. The firm had revenue of $190 million for the quarter, compared to the consensus estimate of $193.32 million. Healthequity had a positive return on equity of 9.48% and a negative net margin of 0.05%. Healthequity's revenue for the quarter was up 118.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.31 earnings per share.
View Healthequity's earnings history
.

What guidance has Healthequity issued on next quarter's earnings?

Healthequity issued an update on its second quarter earnings guidance on Tuesday, June, 2nd. The company provided EPS guidance of $0.23 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.45. The company issued revenue guidance of $168-$173 million, compared to the consensus revenue estimate of $191.51 million.

What price target have analysts set for HQY?

13 Wall Street analysts have issued 12-month target prices for Healthequity's stock. Their forecasts range from $47.00 to $87.00. On average, they anticipate Healthequity's stock price to reach $65.69 in the next twelve months. This suggests a possible upside of 13.3% from the stock's current price.
View analysts' price targets for Healthequity
.

Has Healthequity been receiving favorable news coverage?

News coverage about HQY stock has been trending somewhat negative this week, according to InfoTrie Sentiment. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Healthequity earned a news impact score of -1.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future.
View the latest news about Healthequity
.

Are investors shorting Healthequity?

Healthequity saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 4,460,000 shares, an increase of 17.7% from the May 31st total of 3,790,000 shares. Based on an average daily trading volume, of 923,800 shares, the days-to-cover ratio is currently 4.8 days. Approximately 6.4% of the company's stock are short sold.
View Healthequity's Short Interest
.

Who are some of Healthequity's key competitors?

What other stocks do shareholders of Healthequity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Healthequity investors own include NVIDIA (NVDA), Shopify (SHOP), Square (SQ), Twilio (TWLO), Okta (OKTA), Paypal (PYPL), Trade Desk (TTD), Alibaba Group (BABA), Circle Oil (COP) and Input Capital (INP).

Who are Healthequity's key executives?

Healthequity's management team includes the following people:
  • Mr. Jon Kessler, Pres, CEO & Director (Age 51)
  • Stephen D. Neeleman, Founder & Vice Chairman (Age 51)
  • Mr. Darcy G. Mott, Exec. VP & CFO (Age 66)
  • Ms. Ashley Dreier, Exec. VP, CTO & Chief Information Officer (Age 46)
  • Mr. William Robert Otten, Exec. VP of Sales (Age 54)

What is Healthequity's stock symbol?

Healthequity trades on the NASDAQ under the ticker symbol "HQY."

Who are Healthequity's major shareholders?

Healthequity's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.24%), Wasatch Advisors Inc. (4.47%), William Blair Investment Management LLC (3.56%), Jackson Square Partners LLC (2.87%), Bank of New York Mellon Corp (1.27%) and Victory Capital Management Inc. (1.14%). Company insiders that own Healthequity stock include Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Delano Ladd, Frank Corvino, Jon Kessler and Larry L Trittschuh.
View institutional ownership trends for Healthequity
.

Which major investors are selling Healthequity stock?

HQY stock was sold by a variety of institutional investors in the last quarter, including Jackson Square Partners LLC, FMR LLC, Vanguard Group Inc., Glenmede Trust Co. NA, Macquarie Group Ltd., State of Wisconsin Investment Board, TimesSquare Capital Management LLC, and Moody Lynn & Lieberson LLC. Company insiders that have sold Healthequity company stock in the last year include Ashley Dreier, Darcy G Mott, Jon Kessler, and Larry L Trittschuh.
View insider buying and selling activity for Healthequity
.

Which major investors are buying Healthequity stock?

HQY stock was acquired by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Dorsal Capital Management LLC, Wasatch Advisors Inc., Kayne Anderson Rudnick Investment Management LLC, GW&K Investment Management LLC, Moody Aldrich Partners LLC, Ensign Peak Advisors Inc, and Barclays PLC.
View insider buying and selling activity for Healthequity
.

How do I buy shares of Healthequity?

Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Healthequity's stock price today?

One share of HQY stock can currently be purchased for approximately $57.97.

How big of a company is Healthequity?

Healthequity has a market capitalization of $4.14 billion and generates $531.99 million in revenue each year. The company earns $39.66 million in net income (profit) each year or $1.38 on an earnings per share basis. Healthequity employs 2,931 workers across the globe.

What is Healthequity's official website?

The official website for Healthequity is www.healthequity.com.

How can I contact Healthequity?

Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected]

This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.